These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10595550)

  • 1. Real-time measurements of dark substrate catalysis.
    Xie D; Suvorov L; Erickson JW; Gulnik AS
    Protein Sci; 1999 Nov; 8(11):2460-4. PubMed ID: 10595550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-directed mutagenesis of HIV-1 protease: generation of mutant proteases with increased stability to autodigestion.
    Tomasselli AG; Mildner AM; Rothrock DJ; Sarcich JL; Lull J; Leone J; Heinrikson R
    Adv Exp Med Biol; 1995; 362():473-7. PubMed ID: 8540360
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug-resistant HIV-1 proteases identify enzyme residues important for substrate selection and catalytic rate.
    Ridky TW; Kikonyogo A; Leis J; Gulnik S; Copeland T; Erickson J; Wlodawer A; Kurinov I; Harrison RW; Weber IT
    Biochemistry; 1998 Sep; 37(39):13835-45. PubMed ID: 9753473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 protease substrate-groove: Role in substrate recognition and inhibitor resistance.
    Laco GS
    Biochimie; 2015 Nov; 118():90-103. PubMed ID: 26300060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of tethered human immunodeficiency virus 1 protease containing mutations in the flap region of one subunit.
    Tözsér J; Yin FH; Cheng YS; Bagossi P; Weber IT; Harrison RW; Oroszlan S
    Eur J Biochem; 1997 Feb; 244(1):235-41. PubMed ID: 9063469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A side chain at position 48 of the human immunodeficiency virus type-1 protease flap provides an additional specificity determinant.
    Moody MD; Pettit SC; Shao W; Everitt L; Loeb DD; Hutchison CA; Swanstrom R
    Virology; 1995 Mar; 207(2):475-85. PubMed ID: 7886951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 protease: characterization of a catalytically competent enzyme-substrate intermediate.
    Porter DJ; Hanlon MH; Furfine ES
    Biochemistry; 2002 Jan; 41(4):1302-7. PubMed ID: 11802730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug resistance to HIV-1 protease inhibition requires cooperative coupling between distal mutations.
    Ohtaka H; Schön A; Freire E
    Biochemistry; 2003 Nov; 42(46):13659-66. PubMed ID: 14622012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The amino-acid substituents of dipeptide substrates of cathepsin C can determine the rate-limiting steps of catalysis.
    Rubach JK; Cui G; Schneck JL; Taylor AN; Zhao B; Smallwood A; Nevins N; Wisnoski D; Thrall SH; Meek TD
    Biochemistry; 2012 Sep; 51(38):7551-68. PubMed ID: 22928782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 protease cleavage site prediction based on amino acid property.
    Niu B; Lu L; Liu L; Gu TH; Feng KY; Lu WC; Cai YD
    J Comput Chem; 2009 Jan; 30(1):33-9. PubMed ID: 18496789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrate binding mechanism of HIV-1 protease from explicit-solvent atomistic simulations.
    Pietrucci F; Marinelli F; Carloni P; Laio A
    J Am Chem Soc; 2009 Aug; 131(33):11811-8. PubMed ID: 19645490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate cleavage by HIV-1 proteinase.
    Jupp RA; Richards AD; Phylip LH; Kay J; Konvalinka J; Strop P; Kostka V; Scarborough PE; Farmerie WG; Dunn BM
    Adv Exp Med Biol; 1991; 306():461-7. PubMed ID: 1812743
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of efficiently cleaved substrates for HIV-1 protease using a phage display library and use in inhibitor development.
    Beck ZQ; Hervio L; Dawson PE; Elder JH; Madison EL
    Virology; 2000 Sep; 274(2):391-401. PubMed ID: 10964781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-ray structure of HIV-1 protease in situ product complex.
    Bihani S; Das A; Prashar V; Ferrer JL; Hosur MV
    Proteins; 2009 Feb; 74(3):594-602. PubMed ID: 18704947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the specificity of homo- and heterodimeric linked HIV-1 and HIV-2 proteinase dimers.
    Bagossi P; Cheng YS; Oroszlan S; Tözsér J
    Protein Eng; 1998 Jun; 11(6):439-45. PubMed ID: 9725622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of an in vivo HIV-1 protease mutant in complex with saquinavir: insights into the mechanisms of drug resistance.
    Hong L; Zhang XC; Hartsuck JA; Tang J
    Protein Sci; 2000 Oct; 9(10):1898-904. PubMed ID: 11106162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic properties of saquinavir-resistant mutants of human immunodeficiency virus type 1 protease and their implications in drug resistance in vivo.
    Ermolieff J; Lin X; Tang J
    Biochemistry; 1997 Oct; 36(40):12364-70. PubMed ID: 9315877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of mutant forms of the HIV-1 protease with substrate and inhibitors.
    Darke PL; Kohl NE; Hanobik MG; Leu CT; Vacca JP; Guare JP; Heimbach JC; Dixon RA
    Adv Exp Med Biol; 1991; 306():483-7. PubMed ID: 1812746
    [No Abstract]   [Full Text] [Related]  

  • 19. Support Vector Machines for predicting HIV protease cleavage sites in protein.
    Cai YD; Liu XJ; Xu XB; Chou KC
    J Comput Chem; 2002 Jan; 23(2):267-74. PubMed ID: 11924738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative studies on inhibitors of HIV protease: a target for drug design.
    Jayaraman S; Shah K
    In Silico Biol; 2008; 8(5-6):427-47. PubMed ID: 19374129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.